Queensland

Key facts

Disease
COVID-19
start year
2020
Known Financial Commitments (USD)
$4,500,000
Funder
Coalition for Epidemic Preparedness Innovations (CEPI)
Principal Investigator
Keith Chappel
Research Location
Australia
Lead Research Institution
University of Queensland
Research Priority Alignment
N/A

Research Category
Vaccines research, development and implementation
Research Subcategory
Phase 1 clinical trial
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Clinical Trial, Phase I
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

Full length S-protein Molecular clamp (pre-fusion viral insertion proteins are stabilised using a sequence from HIV. This is applicable to type I and III glycoproteins). Phase I safety and immunogenicity

Publicationslinked via Europe PMC

Last Updated:a day ago

View all publications at Europe PMC

Key facts

Abstract

Publicationslinked via Europe PMC

A Survey of Sedation Practices for Adolescents and Young Adults With Acute Lymphoblastic Leukemia Undergoing Lumbar Puncture.

Scaling and spreading age-friendly care: Early lessons from the VA National Age-Friendly Action Community.

Structural polymorphism and diversity of human segmental duplications.

Funding rules that promote equity in climate adaptation outcomes.

Lymphatic collection and cell isolation from mouse models for multiomic profiling.

The authors reply.

Efficacy of iliopsoas plane block for patients undergoing hip arthroscopy: a prospective, triple-blind, randomized, placebo-controlled trial.

Optimized husbandry and targeted gene-editing for the cnidarian Nematostella vectensis.

The authors reply.